High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
1858	HK$8.63	0.3%	-29.6%	HK$5.7b	HK$20.26	10.3	21.9%	4.8%	Healthcare
1061	HK$2.76	4.5%	-37.4%	HK$1.6b	HK$6.84	4.9	9.8%	5.1%	Pharmaceuticals & Biotech
2279	HK$2.10	3.4%	27.3%	HK$1.1b	HK$2.46	12.3	24.9%	4.2%	Healthcare
1200	HK$2.31	-4.9%	44.4%	HK$1.7b	HK$3.69	3.9	12.5%	2.6%	Real Estate Management and Development
9676	HK$3.78	-5.3%	-44.4%	HK$4.0b	HK$18.50	8.1	33.2%	9.8%	Food, Beverage & Tobacco
2633 New	HK$1.04	-5.5%	-36.2%	HK$2.1b	HK$2.51	6.9	13.7%	8.7%	Pharmaceuticals & Biotech
2199	HK$1.73	-1.7%	-18.4%	HK$2.1b	HK$3.50	8.1	36.7%	6.6%	Consumer Durables
3718	HK$0.40	-3.6%	12.7%	HK$1.4b	HK$0.55	5.6	17.9%	10.0%	Commercial Services
2186	HK$1.88	-2.1%	-47.5%	HK$7.5b	HK$3.49	10.5	18.4%	0%	Pharmaceuticals & Biotech
2420	HK$3.92	0%	21.0%	HK$2.0b	HK$6.78	6.3	22.7%	5.8%	Retail
6051	HK$0.07	-6.7%	-26.3%	HK$2.3b	HK$0.15	12.0	8.9%	n/a	Software
3698	HK$4.53	-7.4%	17.4%	HK$62.9b	HK$4.95	0.3	7.4%	6.4%	Banks
1606 New	HK$1.54	1.3%	-11.5%	HK$19.5b	n/a	3.4	3.3%	7.5%	Diversified Financials
6601	HK$2.02	-6.9%	-27.9%	HK$2.7b	HK$3.76	10.4	11.3%	7.7%	Household
1681	HK$12.86	0.6%	13.6%	HK$10.8b	HK$23.54	8.7	11.2%	6.2%	Pharmaceuticals & Biotech
38	HK$6.80	3.7%	-1.6%	HK$11.6b	HK$12.97	7.8	19.5%	4.5%	Capital Goods

Undiscovered Gems With Strong Fundamentals